U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076729
Company: TARO
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TERIL CARBAMAZEPINE 100MG/5ML SUSPENSION;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/20/2004 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/28/2020 SUPPL-17 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

11/08/2016 SUPPL-13 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

11/08/2016 SUPPL-11 Labeling-Container/Carton Labels, Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.

06/13/2013 SUPPL-9 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

01/24/2012 SUPPL-8 Labeling-Package Insert, Labeling-Medication Guide, REMS-Proposal, Labeling-Container/Carton Labels

Label is not available on this site.

01/27/2010 SUPPL-4 Labeling

Label is not available on this site.

04/17/2008 SUPPL-2 Labeling

Label is not available on this site.

TERIL

SUSPENSION;ORAL; 100MG/5ML
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARBAMAZEPINE CARBAMAZEPINE 100MG/5ML SUSPENSION;ORAL Prescription No AB 075714 CHARTWELL RX
CARBAMAZEPINE CARBAMAZEPINE 100MG/5ML SUSPENSION;ORAL Prescription No AB 214277 NOVITIUM PHARMA
TEGRETOL CARBAMAZEPINE 100MG/5ML SUSPENSION;ORAL Prescription Yes AB 018927 NOVARTIS
TERIL CARBAMAZEPINE 100MG/5ML SUSPENSION;ORAL Prescription No AB 076729 TARO
Back to Top